2022 Annual Meeting | C88 - Spinocerebellar and Spastic Ataxias: Diagnosis and Management

Date Tuesday 04/05/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Oksana Suchowersky, MD, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants should become familiar with the differential diagnoses, work-up, and management of patients with spinocerebellar and spastic ataxias with particular attention to genetic testing, update on pathophysiology, and potential for new and genetic therapies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:40 AM PDT	Speaker	Clinical and Genetic Aspects of the SCAs and Spastic Ataxias Oksana Suchowersky, MD, FAAN
07:00 AM - 07:00 AM PDT	Speaker	Walk-in Slides Oksana Suchowersky, MD, FAAN
07:40 AM - 08:20 AM PDT	Speaker	Pathogenetics and Potential Treatments Guy A. Rouleau, MD, PhD, FAAN
08:20 AM - 08:45 AM PDT	Discussion	Case Presentations Oksana Suchowersky, MD, FAAN, Guy A. Rouleau, MD, PhD, FAAN
08:45 AM - 09:00 AM PDT	Q&A	Questions and Answers Oksana Suchowersky, MD, FAAN, Guy A. Rouleau, MD, PhD, FAAN

Faculty Disclosures
Oksana Suchowersky, MD, FAAN	Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Guy A. Rouleau, MD, PhD, FAAN	Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.